EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review

Trevor J Plowman, Hannah Christensen, Myia Aiges, Emely Fernandez, Mujtaba H Shah iD, Kota V Ramana iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105190 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Trevor J Plowman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT 84606, USA. Hauptthemen laut MEDLINE: Metformin, Hypoglycemic Agents, COVID-19, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, a widely used first-line anti-diabetic therapy for the treatment of type-2 diabetes, has been shown to lower hyperglycemia levels in the blood by enhancing insulin actions. For several decades this drug has been used globally to successfully control hyperglycemia. Lactic acidosis has been shown to be a major adverse effect of metformin in some type-2 diabetic patients, but several studies suggest that it is a typically well-tolerated and safe drug in most patients. Further, recent studies also indicate its potential to reduce the symptoms associated with various inflammatory complications and infectious diseases including coronavirus disease 2019 (COVID-19). These studies suggest that besides diabetes, metformin could be used as an adjuvant drug to control inflammatory and infectious diseases. In this article, we discuss the current understanding of the role of the anti-diabetic drug metformin in the prevention of various inflammatory complications and infectious diseases in both diabetics and non-diabetics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminHypoglycemic AgentsCOVID-19Diabetes Mellitus, Type 2Anti-Inflammatory AgentsInflammationSARS-CoV-2COVID-19 Drug TreatmentHumans

Stichwörter der Autor:innen

COVID-19diabetesinflammationmetforminoxidative stress

Substanzen

MetforminHypoglycemic AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Noorda College of Osteopathic Medicine, Provo, UT 84606, USA.

ORCID-Profile: Mujtaba H Shah, Kota V Ramana

Zitieren

APA

Plowman, T. J., Christensen, H., Aiges, M., Fernandez, E., Shah, M. H., & Ramana, K. V. (2024). Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105190

Vancouver

Plowman TJ, Christensen H, Aiges M, Fernandez E, Shah MH, Ramana KV. Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105190

BibTeX
@article{Plowman2024,
  author = {Plowman, Trevor J and Christensen, Hannah and Aiges, Myia and Fernandez, Emely and Shah, Mujtaba H and Ramana, Kota V},
  title = {Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105190}
}
Kostenlos starten →